Veterinary Medicines

Porcilis APP suspension for injection for pigs

Not authorised
  • Actinobacillus pleuropneumoniae, Inactivated
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
Download as PDF

Product identification

Medicine name:
Porcilis APP suspension for injection for pigs
Active substance:
  • Actinobacillus pleuropneumoniae, Inactivated
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX III toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, Inactivated
    600.00
    milligram(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, outer membrane protein
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX I toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX II toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX III toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Expired
Authorised in:
  • Luxembourg
Package description:
  • Carton with one glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 250 ml (125 doses).
  • Carton with one glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 100 ml (50 doses).
  • Carton with one glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 50 ml (25 doses).
  • Carton with one glass bottle type I (Ph. Eur.) or PET bottle with halogenated rubber stoppers and aluminium closures, containing 20 ml (10 doses).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Le Ministère De La Santé Division De La Pharmacie Et Des Médicaments
Authorisation number:
  • V 817/98/11/0615
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0327/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."